Please login to the form below

Not currently logged in
Email:
Password:

The LionsDen Communications Award for Excellence in Payer and Policy Maker Engagement


The LionsDen Communications Award for Excellence in Payer and Policy Maker Engagement

This award recognises excellence in programmes that engage one or more key payer/stakeholder group(s) (national, regional or European) to develop and broaden debate with clinical, governmental, public and/or other stakeholders to achieve policy change that will lead to improvements in:

  • Health outcomes - delivered by challenging inequality of health outcomes, clinical care or access to medicines or services
  • Clinical practice 
  • Standards of treatment
  • Planning, coordination or delivery of services. 

Work carried out during the two-year period between January 2011 and December 2012 will be eligible.

Submissions entered previously must demonstrate how the programme has been further developed during the additional time period.

Entries are invited from:

  • Charities
  • Patient or professional associations/bodies
  • Pharmaceutical companies
  • Healthcare agencies/consultancies
  • Trade associations.

Judging criteria:

  • Analysis of the problem and evidence of customer insight
  • Quality of the strategy/tactics employed to achieve key objectives
  • Evidence of change effected through communication with national or European payers/policy makers 
  • Evidence of support from a range of interested stakeholders, e.g. healthcare professionals and patient representatives
  • Effectiveness - evidence of changed behaviours and enhanced health outcomes
  • Stakeholder/customer feedback


Sponsors

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....